Agilon Health Inc. (AGL) Misses Q2 EPS by 14c

Agilon Health Inc. (NYSE: AGL) reported Q2 EPS of ($0.25), $0.14 worse than the analyst estimate of ($0.11). Revenue for the quarter came in at $1.4 billion versus the consensus estimate of $1.47 billion.

For earnings history and earnings-related data on Agilon Health Inc. (AGL) click here.

You May Also Be Interested In

• Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
• Tapestry Inc. (TPR) PT Raised to $230 at UBS on Long-Term Growth Potential
• UBS Reiterates Buy Rating on Plains All American (PAA)